Article by Tyler Strause, Skunk Magazine
CBD is the main non-psychoactive cannabinoid in cannabis. CBD has a wide range of potential therapeutic uses. Because of all the uses and because it is non-psychoactive, CBD is often suggested to be beneficial to children, the elderly, and anyone who wants the medicinal benefits of cannabis without the “high.” CBD has been shown to have analgesic, antibacterial, anti-diabetic (reduces blood sugar), antidepressant, anti-emetic, anti-epileptic, anti-inflammatory, anti-insomnia, anti-ischemic (reduces the risk of artery blockage), anti-psoriatic (treats psoriasis), anti-proliferative, anti-psychotic, antioxidant, antispasmodic, anxiolitc, bone stimulant, immunosuppressive, intestinal anti-prokinetc (reduces small intestine contractions), neuroprotective, and vaso-relaxant (reduces vascular tension) effects.
CBN is a mildly psychoactive cannabinoid that comes from the degradation of THC due to exposure to oxygen and heat. This degradation of THC to CBN occurs after an extended period of time. There is usually very little to no CBN in a fresh plant. CBN has been found to be an analgesic, anti-epileptic, antibacterial, anti-inflammatory, anti-insomnia, anti-emetic, anti-proliferative, appetite stimulant, and bone stimulant effects.
CBG is a non-psychoactive cannabinoid that is believed to block the psychoactive effects of THC. CBG has been found to have analgesic, antibacterial, anti-epileptic, anti-inflammatory, anti-insomnia, anti-proliferative, bone stimulant, and neurogenic (promotes growth of new brain cells) effects.
CBC is a non-psychoactive cannabinoid. CBC has a wide range of potential medicinal uses including as an analgesic, anti-depressant, anti-fungal, anti-inflammatory, anti-proliferative, bone stimulant, anxiolitic, and neurogenic (promotes the growth of new brain cells) effects.